Inhibition of Programmed Cell Death-1 in Cytotoxic CD8 + T Cells Exacerbates Pressure Overload–Induced Cardiac Injury
Circulation · 2026
DOI: 10.1161/circulationaha.125.074024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Ming-Ming Wu und 35 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cardiology and Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, NHC Key Laboratory of Cell Transpla…. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, T-Lymphocytes, Cytotoxic, Heart Failure, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The use of anti–programmed cell death-1 (PD-1) antibody increases heart failure (HF) risk in patients with cancer with preexisting cardiovascular conditions. However, the underlying mechanism remains incompletely understood. METHODS: To evaluate the effects of anti–PD-1 antibody on transverse aortic constriction (TAC)–induced cardiac remodeling and HF, anti–PD-1 antibody–treated mice; T cell–, myeloid-, and CD8 + T cell–specific Pdcd1 knockout; C-X-C motif chemokine receptor 3 ( Cxcr3 ) knockout; and granzyme B ( Gzmb ) knockout mice combined with flow cytometry, Western blotting, immunofluorescence staining, pharmacological approaches, and bulk RNA-sequencing analyses were used. RESULTS: Administration of anti–PD-1 antibody, T cell–, or CD8 + T cell–specific Pdcd1 deletion, but not myeloid-specific Pdcd1 knockout, aggravated TAC-induced cardiomyopathy and HF in mice. Mechanistically, PD-1 blockade or deletion increased myocardial infiltration of CXCR3 + CD8 + T cells, leading to granzyme B/perforin–mediated impairment of cardiomyocyte mitochondrial complex I to exacerbate TAC-induced cardiac injury and HF. TAC-enhanced chemotaxis, between cardiac fibroblast–derived CXCL9/CXCL10 and CXCR3 + CD8 + T cells, was a driving force for recruiting CXCR3 + CD8 + T cells under the conditions of PD-1 blockade or deletion. The worsened TAC-induced cardiomyopathy caused by anti–PD-1 antibody or T cell–specific Pdcd1 deletion was rescued by genetic deletion or pharmacological blockade of granzyme B and CXCR3. CONCLUSIONS: Anti–PD-1 antibody enhances myocardial infiltration of CXCR3 + CD8 + T cells under TAC condition through CXCL9/CXCL10–mediated chemotaxis. The increased granzyme B and perforin likely derived from CD8 + T cells impair function of mitochondrial respiratory chain complexes to cause cardiomyocyte apoptosis, thereby exacerbating TAC-induced cardiomyopathy and HF. CXCL9/CXCL10-CXCR3 + CD8 + T cell axis may represent a promising target for combating anti–PD-1 antibody–associated cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Cardiology and Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, NHC Key Laboratory of Cell Transplantation, Key Laboratories of Education Ministry for Myocardial Ischemi…
- Departments of Cardio-Oncology and Pharmacy and Oncological Surgery, Harbin Medical University Cancer Hospital, Institute of Metabolic Disease, Heilongjiang Academy of Medical Science, Heilongjiang Key Laboratory for Me…
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), HMU, Harbin, China (M.-M.W., L.-Y.Y., H.-B.J., Y.J., Z.-W.P., Y.L., Z.-R.Z.).
- Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, China (T.L.).
- Department of Cardio-Oncology, Chongqing University Cancer Hospital, China (H.-X.L.).
- Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, Harbin, China (Y.J., Z.-W.P.).
ORCID-Profile: Ming-Ming Wu, Xiao-Long Liu, Hao-Tian Xu, Qun Shao, Chang-Jiang Yu, Hai-Bo Jia, Yong Ji, Zhen-Wei Pan, Yue Li, Zhi-Ren Zhang
Zitieren
APA
Wu, M. M., Sun, Y., Zhang, Y., Yang, Y. C., He, Z. X., Zhou, S., Wang, X., Xiao, H., Yu, M., Miao, C., Zhang, B. W., Liu, X. L., Chang, J. Y., Zhu, D., Hong, Z., Zhang, M., Xu, H. T., Bi, X., Han, S. Q., …, & Zhang, Z. R. (2026). Inhibition of Programmed Cell Death-1 in Cytotoxic CD8 + T Cells Exacerbates Pressure Overload–Induced Cardiac Injury. Circulation. https://doi.org/10.1161/circulationaha.125.074024
Vancouver
Wu MM, Sun Y, Zhang Y, Yang YC, He ZX, Zhou S, et al. Inhibition of Programmed Cell Death-1 in Cytotoxic CD8 + T Cells Exacerbates Pressure Overload–Induced Cardiac Injury. Circulation. 2026. doi:10.1161/circulationaha.125.074024
BibTeX
@article{Wu2026,
author = {Wu, Ming-Ming and Sun, Yu and Zhang, Yue and Yang, Yan-Chao and He, Zhi-Xi and Zhou, Shuang and Wang, Xia and Xiao, Han and Yu, Miao and Miao, Chang and Zhang, Bo-Wen and Liu, Xiao-Long and Chang, Jie-Yu and Zhu, Di and Hong, Zi and Zhang, Mei and Xu, Hao-Tian and Bi, Xin and Han, Song-Qi and Mao, Jian-Jun and Shi, Jing and Liang, Chen and Wang, Qiu-Shi and Shao, Qun and Zhang, Jun and Yu, Chang-Jiang and Liu, Jian-Yu and Han, Xin-Hao and Liu, Tong and Liu, Hai-Xia and Yu, Lu-Yang and Jia, Hai-Bo and Ji, Yong and Pan, Zhen-Wei and Li, Yue and Zhang, Zhi-Ren},
title = {Inhibition of Programmed Cell Death-1 in Cytotoxic CD8 + T Cells Exacerbates Pressure Overload–Induced Cardiac Injury},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.125.074024}
}
EUVIMED